Breaking News

Halo Adds COO Position

April 9, 2013

Darienzo brings 30 years of experience

Roberto Darienzo has been appointed to the newly created position of chief operating officer at Halo Pharmaceutical. Mr. Darienzo has more than 30 years of industrial experience, with 22 years in technical and international general management roles in the pharmaindustry. He has held positions at Sanofi-Aventis based in Germany, served as vice president Americas Region for Schering-Plough, and subsequently for Merck with responsibility for 13 sites in North and South America.
“Halo is growing very rapidly and our international expansion plans strongly support the need for this new position,” said Clive Bennett, Halo Pharmaceutical’s president and chief executive officer. “In this new role, Roberto will initially be focused on our existing Contract Pharmaceutical Development and Contract Commercial Manufacturing activities in Whippany NJ and Montreal Quebec. We are delighted to have someone of Roberto’s stature in the industry join Halo"
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus